Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 335.00
Bid: 336.50
Ask: 338.50
Change: 19.00 (6.01%)
Spread: 2.00 (0.594%)
Open: 319.50
High: 341.00
Low: 319.50
Prev. Close: 316.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks up as Evergrande fears soothed before Fed

Wed, 22nd Sep 2021 16:54

(Alliance News) - European equities ended higher on Wednesday with fears of a debt crisis at embattled Chinese property firm Evergrande easing, before the US Federal Reserve takes centre-stage with its latest monetary policy decision later this evening.

US equities, which failed to sustain earlier gains on Tuesday and closed mixed, were higher ahead of Wednesday's Fed decision. In London, the gambling sector shone once again on M&A news, while sentiment in Europe was boosted by data showing consumer confidence has crept back above pre-virus levels.

"A series of temporary fixes to ominous global problems has pushed the FTSE 100 back over the psychologically important 7,000 mark, but there's a chance the nuts and bolts may weaken again, and the wheels could fall off the recovery," Hargreaves Lansdown analyst Susannah Streeter commented.

"The deal to settle a domestic bond payment due to be made by the crisis hit Chinese property group Evergrande, seems to have calmed nerves among investors and stopped immediate contagion to other sectors."

The FTSE 100 index ended 102.39 points, or 1.5%, higher at 7,083.37. It was the first time flagship index made a triple-digit points gain since July. The mid-cap FTSE 250 index closed up 173.15 points, 0.7%, at 23,784.54. The AIM All-Share index closed up 8.00 points, 0.6%, at 1,268.13.

The Cboe UK 100 index ended up 1.6% at 704.26. The Cboe 250 was up 1.1%, at 21,619.58. The Cboe Small Companies was 0.8% higher at 15,546.34.

In mainland Europe, the CAC 40 stock index in Paris closed up 1.3% and the DAX 40 index in Frankfurt rose 1.0%.

Evergrande agreed a deal with domestic bondholders that should allow the conglomerate to avoid missing one of its interest payments and avoid default, but its deeper debt burden remains.

The mining sector, with its heavy exposure to the Chinese economy, surged as contagion fears eased. Copper miner Antofagasta climbed 6.9%, Glencore added 3.9% and steel producer Evraz grew 3.3%.

Calming fears of food shortages in Britain, the UK government announced it had struck a deal with carbon dioxide producer CF Industries on Tuesday to provide financial support to restart a plant. Environment Secretary George Eustice said the government would support CF "just for a few weeks" at a cost of "possibly tens of millions" of pounds.

In the food producing space, carbon dioxide's functions include extending the shelf life of food.

Streeter added: "Again this may just be a kludge with only three weeks of financial support guaranteed, and now the energy regulator OFGEM is warning that more energy suppliers could go to the wall. It's clear the crisis in the energy sector is far from over, and companies will be forced to absorb costs, hitting margins or pass rises onto customers, fuelling inflation concerns."

Back in London, Ladbrokes owner Entain surged on the blue-chip index once again, rising 5.1%. The gambling firm provided further details about the takeover approach from Boston, Massachusetts-based Draftkings. Entain had closed 18% higher on Tuesday.

Late Tuesday, Entain had confirmed a report by CNBC that it had received a takeover approach from US sports betting firm DraftKings, but it hadn't provided the price offered.

Entain said on Wednesday that an earlier approach from DraftKings at 2,500 pence per share, which comprised of a combination of DraftKings shares and cash, was rejected. Then, another proposal was received on Sunday by which DraftKings would offer 2,800p per Entain share, consisting of 630p in cash and the balance payable in new DraftKings Class A common shares.

The latest offer represented a premium of 46% to Entain's closing share price on Monday. In response, Entain said it would "carefully consider" the proposal and a further announcement will be made as and when appropriate. Shareholders were urged to take no action.

Draftkings shares were 0.5% lower in New York. London-listed bookmaker were lifted by the news, with Paddy Power owner Flutter closing up 3.8% and 888 Holdings rising 7.1%, while gambling software firm Playtech added 3.1%.

Oxford BioMedica topped London's mid-cap index, surging 11%. The gene and cell therapies company said sales more than doubled in the first half of 2021 thanks to Covid vaccine manufacturing contracts, and it announced an investment from the Serum Institute of India.

The Oxford-based firm made revenue of GBP81.3 million, up from GBP34.0 million in the first half of 2021. That helped it swing to a pretax profit of GBP19.2 million from a loss of GBP6.1 million.

Oxford BioMedica also announced vaccine manufacturer the Serum Institute of India has agreed to make a strategic investment of GBP50.0 million. The Serum Institute will buy 3.4 million newly issued shares for 1,478p each, equal to Tuesday's closing price, giving it a 3.9% stake.

The pound was quoted at USD1.3659 at the London equities close on Wednesday, up from USD1.3643 on Tuesday. Against the Japanese yen, the dollar was trading at JPY109.57, higher against JPY109.26. The euro was priced at USD1.1738, up from USD1.1714.

Consumer confidence in the EU topped pre-virus levels in September, estimates from the European Commission showed on Wednesday. The Directorate-General Economic & Financial Affairs flash consumer confidence estimate showed a rise of 1.1 points in the EU and a 1.3 point hike for the eurozone alone.

At minus 4.0 in the eurozone and minus 5.2 points for the whole of the EU, the two consumer confidence indicators are now above pre-pandemic levels.

"The improvement in the virus situation in the eurozone appears to be lifting sentiment among consumers. The rise in confidence in September means that it averaged -4.6 over Q3 as a whole, up from -5.5 in Q2, when household consumption expanded by 3.7% quarter-on-quarter. This supports our view that household consumption growth accelerated this quarter. Admittedly, retail sales fell in July, and car registrations slid in both July and August, but this is likely the result of consumers switching from buying goods to going out, as restrictions were eased, rather than deciding to no longer spend," Pantheon Macroeconomics analyst Melanie Debono commented.

Ahead of the latest US Federal Reserve interest rate decision, equity prices in New York were higher. The Dow Jones Industrial Average was up 1.1%, the S&P 500 up 1.0% and the Nasdaq Composite was 0.9% higher.

Brent was quoted at USD75.44 a barrel late Wednesday, up sharply from USD73.84 late Tuesday. Gold stood at USD1,778.80 an ounce, down from USD1,781.03.

Analysts at Davy commented: "Fed Chair Jay Powell faces a difficult communications challenge today, especially with President Joe Biden considering his reappointment. Recent softer US data point to a cautious approach from the FOMC as it signals that tapering of the USD120 billion asset purchases will soon begin. However, the 'dot-plot' of rate expectations could provide a hawkish surprise for markets as FOMC members anticipate rate hikes in 2022."

On Thursday, the Bank of England releases its latest interest rate decision at 1200 BST. Analysts widely expect an 8-1 vote in favour of maintaining the quantitative easing programme.

Elsewhere, a slew of flash PMIs are released, including the eurozone at 0900 BST, the UK at 0930 BST and the US at 1445 BST.

Thursday's local corporate calendar has trading statements from postal services firm Royal Mail and financial services company Investec. DFS Furniture releases annual results.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
30 Jun 2023 09:50

LONDON BROKER RATINGS: HSBC likes Aviva; Credit Suisse lifts Drax

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
21 Jun 2023 09:38

LONDON BROKER RATINGS: Barclays cuts Rathbones, but raises Grainger

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning on Tuesday:

Read more
16 Jun 2023 15:43

UK shareholder meetings calendar - next 7 days

Monday 19 June 
All ThingsConsidered Group PLCAGM
Blackbird PLCAGM
Finsbury Food Group PLCAGM
Globalworth Real Estate Investments LtdAGM
Marlowe PLCGM re proposed capital reduction
Metals Exploration PLCAGM
Red Rock Resources PLCGM re security conversion into shares for cash
Savannah Resources PLCAGM
Tuesday 20 June 
Acceler8 Ventures PLCAGM
Afentra PLCAGM
Armadale Capital PLCAGM
Bay Capital PLCAGM
Blackrock Smaller Companies Trust PLCAGM
Block Energy PLCAGM
Corero Network Security PLCAGM
Coro Energy PLCAGM
Crimson Tide PLCAGM
Curtis Banks Group PLCAGM
EPE Special Opportunities LtdAGM
ICG-Longbow Senior Secured UK Property Debt Investments LtdAGM
Jersey Oil & Gas PLCAGM
Kore Potash PLCAGM
Lords Group Trading PLCAGM
Mission Group PLCAGM
North Atlantic Smaller Cos Investment Trust PLCAGM
Red Capital PLCAGM
Saga PLCAGM
SDX Energy PLCAGM
Skillcast Group PLCAGM
Zegona Communications PLCAGM
Wednesday 21 June 
Argentex Group PLCAGM
Clean Power Hydrogen PLCAGM
Eqtec PLCAGM
Hydrogen Utopia International PLCAGM
HSS Hire Group PLCAGM
Intelligent Ultrasound Group PLCAGM
JD.com IncAGM
RTW Venture Fund LtdAGM
Schroders Capital Global Innovation Trust PLCAGM
Sivota PLCAGM
Numis Corp PLCGM re acquisition by Deuche Bank AG
THG PLCAGM
UK Commercial Property REIT LtdAGM
Thursday 22 June 
Alphawave IP Group PLCAGM
Angling Direct PLCAGM
Anglo Asian Mining PLCAGM
boohoo Group PLCAGM
Card Factory PLCAGM
Ergomed PLCAGM
Futura Medical PLCAGM
Good Energy Group PLCAGM
Grand Vision Media Holdings PLCAGM
Longboat Energy PLCAGM
MaxRets Ventures PLCAGM
Pathfinder Minerals PLCAGM
RBG Holdings PLCAGM
Sanderson Design Group PLCAGM
Team17 Group PLCAGM
Trellus Health PLCAGM
Whitbread PLCAGM
Friday 23 June 
Mears Group PLCAGM
Ocean Harvest Technology Group PLCAGM
Oxford Biomedica PLCAGM
Pelatro PLCAGM
Petrofac LtdAGM
Princess Private Equity Holding LtdAGM
Rathbones Group PLCGM re agreement regarding all-share combination with Invested Wealth & Investment Ltd
Supply@Me Capital PLCGM re open offer warrantholders
Vietnam Enterprise Investments LtdAGM
VPC Specialty Lending Investments PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
24 May 2023 09:31

LONDON BROKER RATINGS: Morgan Stanley raises Deliveroo to 'overweight'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
15 May 2023 11:07

SMALL-CAP WINNERS & LOSERS: PPHE extends Radisson partnership

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday.

Read more
15 May 2023 10:12

IN BRIEF: Oxford BioMedica launches lentiviral vector system

Oxford BioMedica PLC - Oxfordshire, England-based gene and cell therapy group - Launches its 4th generation lentiviral vector delivery system, TetraVecta. Says the TetraVecta system enhances the development of more effective lentiviral vector-based therapies. Firm says this enables cell and gene therapy companies to overcome previous barriers in therapeutic development.

Read more
25 Apr 2023 11:34

Oxford BioMedica swings to full-year loss amid lower volumes

(Alliance News) - Oxford BioMedica PLC on Tuesday reported a drop in annual revenue and swung to a loss, as a result of lower volumes and higher costs.

Read more
13 Apr 2023 15:47

UK earnings, trading statements calendar - next 7 days

Friday 14 April 
888 Holdings PLCFull Year Results
888 Holdings PLCTrading Statement
AO World PLCTrading Statement
CMC Markets PLCTrading Statement
Devro PLCFull Year Results
Flowtech Fluidpower PLCFull Year Results
Hays PLCTrading Statement
Monday 17 April 
Arecor Therapeutics PLCFull Year Results
Ashmore Group PLCTrading Statement
Diaceutics PLCFull Year Results
PageGroup PLCTrading Statement
Sirius Real Estate LtdTrading Statement
Surface Transforms PLCFull Year Results
Tuesday 18 April 
ASA International Group PLCFull Year Results
Billington Holdings PLCFull Year Results
easyJet PLCTrading Statement
IntegraFin Holdings PLCTrading Statement
LifeSafe Holdings PLCFull Year Results
Moneysupermarket.com Group PLCTrading Statement
Ninety One PLC and LtdTrading Statement
Petra Diamonds LtdTrading Statement
Property Franchise Group PLCFull Year Results
Schroder UK Public Private Trust PLCFull Year Results
THG PLCFull Year Results
THG PLCTrading Statement
Qinetiq Group PLCTrading Statement
Xeros Technology Group PLCFull Year Results
Wednesday 19 April 
Antofagasta PLCTrading Statement
discoverIE Group PLCTrading Statement
Distribution Finance Capital Holdings PLCFull Year Results
Entain PLCQ1 Results
Liontrust Asset Management PLCTrading Statement
Hunting PLCTrading Statement
M Winkworth PLCFull Year Results
Network International Holdings PLCTrading Statement
Quilter PLCTrading Statement
Thursday 20 April 
AJ Bell PLCTrading Statement
Centamin PLCTrading Statement
Dianomi PLCFull Year Results
Dunelm Group PLCQ3 Results
Foxtons Group PLCTrading Statement
GB Group PLCTrading Statement
Hochschild Mining PLCFull Year Results
Intelligent Ultrasound Group PLCFull Year Results
Oxford BioMedica PLCFull Year Results
PensionBee Group PLCTrading Statement
Rentokil Initial PLCTrading Statement
Rio Tinto PLCTrading Statement
Segro PLCTrading Statement
WH Smith PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
13 Mar 2023 12:18

SUMMARY: London listings with exposure to Silicon Valley Bank

(Alliance News) - The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
20 Feb 2023 08:45

IN BRIEF: Oxford BioMedica confirms start date of Mathias as new CEO

Oxford BioMedica PLC - Oxfordshire, England-based gene and cell therapy group - Says Frank Mathias, previously announced as the company's new chief executive officer, will officially join the firm on March 27. Mathias joins Oxford Biomedica from Rentschler Biopharma SE, where he has been CEO since 2016.

Read more
14 Dec 2022 10:25

IN BRIEF: Oxford Biomedica subsidiary signs deals with three US firms

Oxford Biomedica PLC- Oxfordshire, England-based gene and cell therapy group - Says subsidiary Oxford Biomedica Solutions LLC has signed agreements with three unnamed US biotechnology firms. Under the agreements, the subsidiary will provide its full platform offering to support the new partners' pre-clinical gene therapy programmes.

Read more
14 Dec 2022 07:53

LONDON BRIEFING: UK inflation in November cools off record high

(Alliance News) - Stocks in London are set to open lower on Wednesday, ahead of a key interest rate decision by the US Federal Reserve later in the day.

Read more
28 Nov 2022 11:43

Liberum cuts target price for Oxford Biomedica, saying it still lacks sufficient scale

(Sharecast News) - Analysts at Liberum cut their target price for shares Oxford Biomedica arguing that the company's pan-vector offering had yet to reach sufficient scale in order to deliver sustainable profitability.

Read more
22 Nov 2022 10:15

IN BRIEF: Oxford BioMedica appoints Frank Mathias as new CEO

Oxford BioMedica PLC - Oxfordshire, England-based gene and cell therapy group - Appoints Frank Mathias as chief executive officer and board director, effective March 2023.

Read more
22 Nov 2022 09:30

Oxford Biomedica taps Frank Mathias as its new CEO

(Sharecast News) - Gene and cell therapy specialist Oxford Biomedica announced the appointment of Dr Frank Mathias as its new chief executive officer and a board director on Tuesday, effective from March.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.